JNJ · News · 20260911N
Orthopaedics Separation
JOHNSON & JOHNSON · 2026-09-11 · Importance 64 · Surprise 42 · Contradicted
Apollo Global Management is reportedly discussing a potential acquisition of Johnson & Johnson’s DePuy Synthes orthopedics unit for approximately $20 billion. DePuy Synthes generated $9.3 billion in revenue during 2025. J&J has been evaluating strategic alternatives for the unit, including a potential spin-off into a publicly traded company. A divestiture would support J&J’s strategy of concentrating on higher-growth healthcare segments and follows increased private-equity interest in healthcare assets.
Key facts
- Johnson & Johnson has been exploring options for the DePuy Synthes unit, which generated $9.3 billion in 2025. source
- The DePuy Synthes unit faces lawsuits and there is a potential spin-off into a publicly traded company. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | negative | contingent | -5.5% | Johnson & Johnson has been exploring options for the DePuy Synthes unit, which generated $9.3 billion in 2025. |